India  

Cadila Healthcare

Indian multinational pharmaceutical company

Cadila Healthcare    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Cadila Healthcare: Indian multinational pharmaceutical company
Cadila Healthcare Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India primarily engaged in the manufacture of generic drugs. It ranked 100th in the Fortune India 500 list in 2020.

0
shares
ShareTweetSavePostSend
 
What is Virafin? How does the Zydus Cadila drug work? | Oneindia News [Video]

What is Virafin? How does the Zydus Cadila drug work? | Oneindia News

Zydus Cadila's Virafin has been approved for emergency use to treat moderate Covid-19 patients by the drug controller general of india. How does Virafin work? #Virafin #ZydusCadila #CovidDrug

Credit: Oneindia     Duration: 01:24Published

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases [Video]

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by..

Credit: ANI     Duration: 02:01Published

You Might Like


Zydus Cadila's Virafin granted restricted emergency use approval for treating Covid patients: DBT


IndiaTimes - Published Also reported by •DNA

Zydus Cadila Healthcare starts producing Covid-19 vaccine


IndiaTimes - Published

Zydus Cadila gets DCGI nod for hepatitis drug for Covid-19 treatment

Drug firm Zydus Cadila on Friday said it has received restricted emergency use approval from the Indian drug regulator for the use of Pegylated Interferon alpha-2b (PegIFN) in treating moderate..
IndiaTimes - Published

Zydus vaccine to cover children too


IndiaTimes - Published

Companies set to double Remdesivir output

Even as the Centre announced a slew of measures to improve access of Covid-19 therapy, Remdesivir, major players including Zydus Cadila, Cipla, Mylan and Dr Reddy’s are ramping up production, which..
IndiaTimes - Published

Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine


IndiaTimes - Published

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1

Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical trial of its novel molecule ZYIL1, indicated for use as an..
IndiaTimes - Published

Covid-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy


IndiaTimes - Published

Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility

Prime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad. After..
IndiaTimes - Published

PM Modi reaches Ahmedabad to review coronavirus vaccine development

Prime Minister Narendra Modi landed here on Saturday as part of his three-city visit to ireview coronavirus vaccine development work at facilities there, an official said. From the airport, Modi..
IndiaTimes - Published

PM to visit Zydus' Covid-19 vaccine development centre in Gujarat


IndiaTimes - Published

PM to visit vaccine centres in 3 cities

While in Hyderabad, the PM will visit vaccine maker Bharat Biotech’s facilities, where work on the development of India’s first indigenous Covid-19 vaccine, Covaxin, is under way, he will drop in..
IndiaTimes - Published

India to get COVID-19 vaccine by mid-2021, says Biocon's Kiran Mazumdar-Shaw

Besides, Bharat Biotech, Zydus Cadila Ltd is also in Phase 2 of human clinical trials of a COVID-19 vaccine.
DNA - Published

For high-risk groups, government plans to fast-track vaccine

India has three vaccines in advanced stages of trial. The vaccine candidate developed by Oxford University and AstraZeneca and proposed in India by Serum Institute is ahead and is set to enter phase 3...
IndiaTimes - Published

Covid-19 vaccine: Govt panel meets representatives of leading domestic manufacturers

The national expert group on vaccine administration for Covid-19 met representatives of leading domestic manufactures, including Serum Institute of India, Bharat Biotech and Zydus Cadila, on Monday to..
IndiaTimes - Published

National Expert Group discusses vaccine development with domestic manufactures

National Expert Group on Vaccine Administration on Monday met leading domestic vaccine manufactures- Serum Institute of India, Pune; Bharat Biotech, Hyderabad; Zydus Cadila, Ahmedabad; Gennova..
DNA - Published

Zydus' 'budget' injection costs 2,800/shot

Ahmedabad-based Zydus Cadila announced the launch of its anti-viral Remdesivir drug at Rs 2,800 per injection, making it the "most economical" brand in the country.
IndiaTimes - Published

COVID-19: Drug firm Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800

Yet again, India witnessed the highest-ever single-day spike of 66,999 new COVID-19 cases the last 24 hours.
DNA - Published

Zydus Cadila gets USFDA nod for drug trials to treat chemotherapy-induced anemia

In a regulatory filing, Zydus Cadila said it has received approval from the US Food and Drug Administration (USFDA) to initiate clinical trials of Desidustat in CIA. Zydus Cadila Chairman Pankaj R..
IndiaTimes - Published

Seven Indian pharma players race to develop Covid-19 vaccine

At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already..
IndiaTimes - Published

Zydus Cadila starts human trials of vaccine


IndiaTimes - Published

India's Zydus begins human trials for potential Covid-19 vaccine

Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential Covid-19 vaccine. ​​ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and..
IndiaTimes - Published

Hyd co to start human trials on Covid vaccine soon; Cadila too gets DCGI nod for vaccine trial


IndiaTimes - Published

Covid-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

After Bharat Biotech's Covaxin, another potential Covid-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got the nod from the Drugs Controller General of India (DCGI) on..
IndiaTimes - Published

India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir

Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive licensing pact with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show..
Reuters India - Published

India's Zydus Cadila signs pact with Gilead to make remdesivir

Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in..
Reuters India - Published